ARCHIVES

UHC Expands Risk Models To Include 25 Cancer Variables

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

Immune Systems Don’t Stop, Causing Fatigue For Survivors

May 26, 2006

When Doctors Take Work Home: Houston Burglary Points to Security Breach

June 29, 2012